Molecular biomarkers in endometrial hyperplasias predict cancer progression

American Journal of Obstetrics and Gynecology

Volumn 204, Issue 4, 2011, Pages 357.e1-357.e12

  Steinbakk, Anita ^a,b   Gudlaugsson, Einar ^a,b   Aasprong, Ole Gunnar ^a   Skaland, Ivar ^a   Malpica, Anais ^c   Feng, Weiwei ^d   Janssen, Emiel A M ^a   Baak, Jan P ^a,b  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c UNIVERSITY OF TEXAS   (United States)

^d FUDAN UNIVERSITY   (China)

Author keywords

COX2; D score; endometrial hyperplasia; prognostic

Indexed keywords

BETA CATENIN; BIOLOGICAL MARKER; CYCLIN E; CYCLOOXYGENASE 2; CYTOKERATIN 5; CYTOKERATIN 6; HISTONE H3; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN BCL 2; PROTEIN KINASE B; PROTEIN P16; PROTEIN P21; PROTEIN P27; PROTEIN P53; PROTEIN P63; SURVIVIN;

ARTICLE; CANCER CLASSIFICATION; CANCER GROWTH; ENDOMETRIAL INTRAEPITHELIAL NEOPLASIA; ENDOMETRIUM CANCER; ENDOMETRIUM HYPERPLASIA; HUMAN; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; SCORING SYSTEM;

EID: 79953271049     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2010.12.007     Document Type: Article

References (34)

1. A. Jemal, R. Siegel, and E. Ward Cancer statistics 2006. CA Cancer J Clin 56 2006 106 130
2. J.P. Baak, G.L. Mutter, and S. Robboy The molecular genetics and morphometry-based endometrial intraepithelial neoplasia classification system predicts disease progression in endometrial hyperplasia more accurately than the 1994 World Health Organization classification system Cancer 103 2005 2304 2312 (Pubitemid 40686575)
3. M.C. Lin, L. Lomo, and J.P. Baak Squamous morules are functionally inert elements of premalignant endometrial neoplasia Mod Pathol 22 2009 167 174
4. N. Izadi-Mood, M. Khaniki, G. Irvanloo, S.A. Ahmadi, H. Hayeri, and A. Meysamie Determining the inter- and intraobserver reproducibility of the diagnosis of endometrial hyperplasia subgroups and well-differentiated endometrioid carcinoma in endometrial curettage specimens Arch Iran Med 12 2009 377 382
5. K.H. Allison, S.D. Reed, L.F. Voigt, C.D. Jordan, K.M. Newton, and R.L. Garcia Diagnosing endometrial hyperplasia: why is it so difficult to agree? Am J Surg Pathol 32 2008 691 698 (Pubitemid 351600820)
6. G.L. Mutter Histopathology of genetically defined endometrial precancers Int J Gynecol Pathol 19 2000 301 309
7. G.L. Mutter, M.C. Lin, and J.T. Fitzgerald Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers J Natl Cancer Inst 92 2000 924 930
8. J.P. Baak, B. Van Diermen, and A. Steinbakk Lack of PTEN expression in endometrial intraepithelial neoplasia is correlated with cancer progression Hum Pathol 36 2005 555 561 (Pubitemid 40776009)
9. G.L. Mutter Endometrial intraepithelial neoplasia (EIN): will it bring order to chaos? The Endometrial Collaborative Group Gynecol Oncol 76 2000 287 290 (Pubitemid 30131494)
10. A. Steinbakk, I. Skaland, and E. Gudlaugsson The prognostic value of molecular biomarkers in tissue removed by curettage from FIGO stage 1 and 2 endometrioid type endometrial cancer Am J Obstet Gynecol 200 2009 78.e1 78.e8
11. G.L. Mutter, J.P. Baak, C.P. Crum, R.M. Richart, A. Ferenczy, and W.C. Faquin Endometrial precancer diagnosis by histopathology, clonal analysis, and computerized morphometry J Pathol 190 2000 462 469 (Pubitemid 30163587)
12. J.P. Baak, J.J. Nauta, E.C. Wisse-Brekelmans, and P.D. Bezemer Architectural and nuclear morphometrical features together are more important prognosticators in endometrial hyperplasias than nuclear morphometrical features alone J Pathol 154 1988 335 341
13. J.P. Baak, E.C. Wisse-Brekelmans, J.C. Fleege, H.W. van der Putten, and P.D. Bezemer Assessment of the risk of endometrial cancer in hyperplasia, by means of morphological and morphometrical features Pathol Res Pract 188 1992 856 859
14. J.P. Baak, A. Orbo, and P.J. van Diest Prospective multicenter evaluation of the morphometric D-score for prediction of the outcome of endometrial hyperplasias Am J Surg Pathol 25 2001 930 935 (Pubitemid 32594987)
15. H. Korner, K. Soreide, P.J. Stokkeland, and J.A. Soreide Diagnostic accuracy of serum-carcinoembryonic antigen in recurrent colorectal cancer: a receiver operating characteristic curve analysis Ann Surg Oncol 14 2007 417 423 (Pubitemid 46175284)
16. A. Nasir, D. Boulware, and H.E. Kaiser Cyclooxygenase-2 (COX2) expression in human endometrial carcinoma and precursor lesions and its possible use in cancer chemoprevention and therapy In Vivo 21 2007 35 43
17. S. Erkanli, F. Bolat, F. Kayaselcuk, B. Demirhan, and E. Kuscu COX2 and survivin are overexpressed and positively correlated in endometrial carcinoma Gynecol Oncol 104 2007 320 325 (Pubitemid 46135664)
18. F.J. Orejuela, L.M. Ramondetta, and J. Smith Estrogen and progesterone receptors and cyclooxygenase-2 expression in endometrial cancer, endometrial hyperplasia, and normal endometrium Gynecol Oncol 97 2005 483 488 (Pubitemid 40614893)
19. Q.J. Cao, M.H. Einstein, P.S. Anderson, C.D. Runowicz, R. Balan, and J.G. Jones Expression of COX2, Ki-67, cyclin D1, and P21 in endometrial endometrioid carcinomas Int J Gynecol Pathol 21 2002 147 154 (Pubitemid 34260635)
20. K.H. Lu, and R.R. Broaddus Future challenges in clinical and translational research for endometrial cancer Int J Gynecol Cancer 2005 398 411
21. M. Lambropoulou, N. Papadopoulos, and G. Tripsianis Co-expression of survivin, c-erbB2, and cyclooxygenase-2 (COX2): prognostic value and survival of endometrial cancer patients J Cancer Res Clin Oncol 136 2010 427 435
22. N.A. Boldarian, K.M. Pozharisskii, V.L. Vinokurov, V.P. Ten, and E.A. Samsonova Prognostic significance of cyclooxygenase (COX-1 and COX2) expression in endometrial carcinoma (clinical and immunohistochemical study) Vopr Onkol 54 2008 40 46
23. Y. Ohno, S. Ohno, and N. Suzuki Role of cyclooxygenase-2 in immunomodulation and prognosis of endometrial carcinoma Int J Cancer 114 2005 696 701 (Pubitemid 40344430)
24. M. Lambropoulou, G. Alexiadis, V. Limberis, N. Nikolettos, and G. Tripsianis Clinicopathologic and prognostic significance of cyclooxygenase-2 expression in endometrial carcinoma Histol Histopathol 20 2005 753 759 (Pubitemid 40932593)
25. G. Ferrandina, F.O. Ranelletti, and V. Gallotta Expression of cyclooxygenase-2 (COX2), receptors for estrogen (ER), and progesterone (PR), p53, ki67, and neu protein in endometrial cancer Gynecol Oncol 98 2005 383 389 (Pubitemid 41169148)
26. J.M. Fowler, N. Ramirez, and D.E. Cohn Correlation of cyclooxygenase-2 (COX2) and aromatase expression in human endometrial cancer: tissue microarray analysis Am J Obstet Gynecol 192 2005 1262 1273 (Pubitemid 40487806)
27. C.N.J. Landen, S.P. Mathur, M.S. Richardson, and W.T. Creasman Expression of cyclooxygenase-2 in cervical, endometrial, and ovarian malignancies Am J Obstet Gynecol 188 2003 1174 1176 (Pubitemid 36589093)
28. P.J. Uotila, R.U. Erkkola, and P.J. Klemi The expression of cyclooxygenase-1 and -2 in proliferative endometrium and endometrial adenocarcinoma Ann Med 34 2002 428 433 (Pubitemid 36026774)
29. A. Shimizu, T. Maruyama, K. Tamaki, H. Uchida, H. Asada, and Y. Yoshimura Impairment of decidualization in SRC-deficient mice Biol Reprod 73 2005 1219 1227 (Pubitemid 41698612)
30. J.G. Cheng, and C.L. Stewart Loss of cyclooxygenase-2 retards decidual growth but does not inhibit embryo implantation or development to term Biol Reprod 68 2003 401 404 (Pubitemid 36139304)
31. P.L. Pakrasi, and A.K. Jain Cyclooxygenase-2 derived PGE2 and PGI2 play an important role via EP2 and PPARdelta receptors in early steps of oil induced decidualization in mice Placenta 29 2008 523 530
32. N. Horree, P.J. van Diest, P. van der Groep, D.M. Sie-Go, and A.P. Heintz Progressive derailment of cell cycle regulators in endometrial carcinogenesis J Clin Pathol 61 2008 36 42 (Pubitemid 351158223)
33. K. Milde-Langosch, L. Riethdorf, A.M. Bamberger, and T. Loning P16/MTS1 and pRB expression in endometrial carcinomas Virchows Arch 434 1999 23 28 (Pubitemid 29184898)
34. G.L. Mutter, T.A. Ince, J.P. Baak, G.A. Kust, X.P. Zhou, and C. Eng Molecular identification of latent precancers in histologically normal endometrium Cancer Res 61 2001 4311 4314 (Pubitemid 32685749)